Raj Devraj

Raj Devraj, CEO of Rectify Pharmaceuticals and a seasoned venture partner, shares his insights on the ever-evolving biotech landscape. He reflects on his journey from India to pharmaceutical success, emphasizing the need for determination and aggressive advancement. The conversation dives into the challenges of securing funding in a risk-averse market and the importance of strategic team-building. Raj also discusses the pivot to hepatobiliary diseases, advocating for innovative, broad applications of biotechnology while stressing mentorship and solid planning for aspiring entrepreneurs.